tiprankstipranks
FitLife Brands (FTLF)
NASDAQ:FTLF
US Market

FitLife Brands (FTLF) AI Stock Analysis

Compare
31 Followers

Top Page

FT

FitLife Brands

(NASDAQ:FTLF)

74Outperform
FitLife Brands demonstrates strong financial performance with solid revenue and profit growth, effective cost management, and robust cash flow generation. However, technical indicators suggest bearish trends, and while the valuation is reasonable, the lack of a dividend might deter some investors. The recent earnings call underscores the company's growth potential but also highlights some challenges that need addressing.
Positive Factors
Earnings Performance
Earnings growth significantly outpaced revenue growth, with EPS rising 40% to $0.21.
Market Position
FitLife's unique position executing a roll-up strategy in the fragmented supplement industry offers a compelling opportunity for investors.
Revenue Growth
Revenue grew 13% year-over-year to $15.0M, driven by strong online sales and contributions from recently acquired brands.
Negative Factors
Share Price Concerns
Despite significant share price growth, further multiple expansion can be supported by growth in existing brands and expanding the portfolio with new brands.

FitLife Brands (FTLF) vs. S&P 500 (SPY)

FitLife Brands Business Overview & Revenue Model

Company DescriptionFitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. It offers weight loss, general health, and sports nutrition supplements; precision sports nutrition formulations for professional muscular development; weight loss and sports nutrition performance enhancing supplements for fitness enthusiasts; and men's health and weight loss formulations, as well as other diet, health, and sports nutrition supplements and related products; and sports nutritional products, energy and weight loss products, and meal replacements. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize through franchised stores, as well as through various retail locations, including specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.
How the Company Makes MoneyFitLife Brands generates revenue through the sale of its nutritional supplements and wellness products. The company's primary revenue streams include direct sales to consumers through online platforms and wholesale distribution to various retail partners, including specialty health stores and fitness centers. FitLife Brands also engages in strategic partnerships and collaborations with key industry players to expand its market reach and enhance its product offerings. Additionally, the company invests in marketing and brand-building initiatives to drive consumer engagement and increase sales.

FitLife Brands Financial Statement Overview

Summary
FitLife Brands presents a strong overall financial position with solid revenue growth, healthy profitability, conservative leverage, and robust cash flow generation. The company's financial stability and effective management practices provide a solid foundation for sustaining growth in the competitive packaged foods industry. Continued focus on maintaining profitability margins and leveraging growth opportunities will be key to future success.
Income Statement
85
Very Positive
FitLife Brands has demonstrated strong revenue growth with a consistent upward trajectory, notably a 22.35% increase from 2023 to 2024. The company's gross profit margin is robust at 43.55%, complemented by a healthy net profit margin of 13.93%. EBIT and EBITDA margins are also strong at 20.36% and 20.71% respectively, indicating effective cost management and operational efficiency. Overall, the income statement reflects solid profitability, though continued vigilance on maintaining margins is recommended.
Balance Sheet
78
Positive
FitLife Brands exhibits a solid balance sheet with a low debt-to-equity ratio of 0.14, indicating conservative leverage. The equity ratio stands at 61.72%, showcasing a strong equity base relative to total assets. Return on equity is impressive at 24.86%, highlighting effective utilization of equity to generate profits. While the balance sheet is stable, attention to maintaining low leverage and high equity levels will be crucial.
Cash Flow
82
Very Positive
The company shows significant growth in free cash flow, with a 133.35% increase from 2023 to 2024. Operating cash flow to net income ratio is 1.07, indicating good cash generation relative to net income. The free cash flow to net income ratio is 1.07, demonstrating strong cash flow conversion. The cash flow statement reflects healthy cash management and operational strength, supporting future growth and investment.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
62.76M64.47M52.70M28.80M27.90M21.74M
Gross Profit
27.16M28.08M21.43M12.03M12.49M9.39M
EBIT
12.30M13.12M7.55M5.70M6.22M4.20M
EBITDA
12.68M13.35M8.12M5.89M6.81M4.38M
Net Income Common Stockholders
8.39M8.98M5.30M4.43M5.41M8.82M
Balance SheetCash, Cash Equivalents and Short-Term Investments
588.66K4.47M1.14M13.28M9.90M6.34M
Total Assets
5.20M58.53M55.35M25.71M21.48M16.77M
Total Debt
1.05M4.91M20.15M103.00K158.00K661.00K
Net Debt
466.05K444.00K19.01M-13.17M-9.74M-5.67M
Total Liabilities
1.79M22.41M28.31M4.32M4.19M4.74M
Stockholders Equity
3.41M36.13M27.04M21.39M17.29M12.03M
Cash FlowFree Cash Flow
10.04M9.60M4.11M4.13M4.48M5.72M
Operating Cash Flow
10.10M9.61M4.22M4.13M4.48M5.72M
Investing Cash Flow
-17.02M-10.00K-35.99M0.00-529.00K0.00
Financing Cash Flow
3.17M-6.98M20.30M-750.00K-390.00K350.00K

FitLife Brands Technical Analysis

Technical Analysis Sentiment
Negative
Last Price12.30
Price Trends
50DMA
14.57
Negative
100DMA
15.38
Negative
200DMA
15.73
Negative
Market Momentum
MACD
-0.65
Positive
RSI
28.79
Positive
STOCH
16.37
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FTLF, the sentiment is Negative. The current price of 12.3 is below the 20-day moving average (MA) of 13.43, below the 50-day MA of 14.57, and below the 200-day MA of 15.73, indicating a bearish trend. The MACD of -0.65 indicates Positive momentum. The RSI at 28.79 is Positive, neither overbought nor oversold. The STOCH value of 16.37 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FTLF.

FitLife Brands Risk Analysis

FitLife Brands disclosed 25 risk factors in its most recent earnings report. FitLife Brands reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

FitLife Brands Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
THTHG
82
Outperform
$6.29B14.9516.03%2.00%4.07%1110.92%
74
Outperform
$109.24M13.3928.45%22.33%65.30%
70
Outperform
$239.73M30.674.98%2.03%-47.76%
HLHLF
66
Neutral
$891.55M3.54-31.74%-1.37%75.47%
66
Neutral
$515.34M12.407.76%-7.22%-33.67%
63
Neutral
$20.94B14.39-10.05%3.13%1.25%3.11%
MEMED
55
Neutral
$143.72M72.201.02%-43.80%-97.89%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FTLF
FitLife Brands
11.49
-1.41
-10.93%
HLF
Herbalife
8.46
0.81
10.59%
MED
Medifast
13.06
-20.82
-61.45%
NATR
Nature's Sunshine Products
12.39
-7.07
-36.33%
THG
Hanover Insurance
175.14
47.77
37.50%
USNA
USANA Health
25.47
-20.35
-44.41%

FitLife Brands Earnings Call Summary

Earnings Call Date: Mar 27, 2025 | % Change Since: -11.64% | Next Earnings Date: May 14, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted strong overall financial performance for 2024, with significant growth in revenue, profit, and online sales. However, challenges were noted in the Legacy FitLife segment, mainly due to a dispute with GNC, and expected declines in MRC revenues for Q1 2025, which balance the positive achievements.
Highlights
Significant Revenue and Profit Growth
For the full year 2024, total revenue increased 22% year-over-year to $64.5 million. Gross profit increased 31%, and gross margin expanded from 40.7% to 43.6%. Net income increased 70% to $9 million.
Impressive Online Sales Performance
Online sales grew 29% year-over-year and represented 67% of the Company's total revenue.
Robust Adjusted EBITDA Growth
Adjusted EBITDA for the full year increased 39% to $14.1 million.
Mimi's Rock Contribution Growth
MRC's gross margin increased year-over-year from 40.4% to 48.7%, and contribution as a percentage of revenue increased from 28.2% to 37.1%.
MusclePharm Brand Developments
Launch of the new MusclePharm Pro Series, including nine SKUs in a Vitamin Shoppe pilot, and introduction of new flavors in protein bars and ready-to-drink proteins.
Lowlights
Legacy FitLife Revenue Decline
Total Legacy FitLife revenue for Q4 2024 was $5.3 million, representing a 13% year-over-year decline. Wholesale revenue declined 20%, and online revenue declined 1%.
Commercial Dispute with GNC
A dispute with the largest customer, GNC, led to a halt in order acceptance from December 1, 2024, through January 23, 2025, affecting sales.
Challenges with MRC Skin Care Brands
Revenue for the skin care brands declined 38% in Q4 2024 due to unprofitable revenue rationalization.
Expected Revenue Decline in Q1 2025
Consolidated revenue for Q1 2025 is estimated to be 4% to 6% lower than Q1 2024, mainly due to tough comparisons with MRC's strong performance in early 2024.
Company Guidance
During the FitLife Brands Fourth Quarter 2024 earnings call, CEO Dayton Judd reported a 22% year-over-year increase in total revenue, reaching $64.5 million, with online sales growing 29% and contributing 67% of total revenue. The company achieved a gross profit increase of 31%, expanding the gross margin from 40.7% to 43.6%. Contribution surged by 37% to $23.5 million. Net income rose 70% to $9 million, with basic EPS up 66% to $0.98 and fully diluted EPS up 69% to $0.91. Adjusted EBITDA increased 39% to $14.1 million. For the fourth quarter, total revenue grew 13% to $15 million, with online revenue up 12% to $10.1 million. Gross profit increased 16% to $6.2 million, and gross margin expanded to 41.4%. The company ended the year with $13.1 million outstanding on term loans, $4.5 million in cash, and no balance on its revolving line of credit, resulting in a net debt of $8.6 million. Judd also discussed a commercial dispute with GNC, which was resolved in January 2025, and highlighted ongoing efforts to optimize brand performance and navigate tariff impacts.

FitLife Brands Corporate Events

M&A TransactionsBusiness Operations and StrategyFinancial Disclosures
FitLife Brands Reports Strong 2024 Financial Performance
Positive
Mar 27, 2025

FitLife Brands reported a strong financial performance for the fourth quarter and full year of 2024, with total revenue for the year increasing by 22% to $64.5 million and net income rising by 70% to $9.0 million. The company’s online sales, which accounted for 67% of total revenue, grew by 29% over the year, while acquisitions of Mimi’s Rock Corp and MusclePharm assets contributed significantly to wholesale revenue. The improved financial results reflect FitLife’s strategic focus on expanding its market presence and enhancing profitability, positioning the company favorably within the nutritional supplements industry.

Business Operations and StrategyFinancial Disclosures
FitLife Brands Projects Strong Financial Growth for 2024
Positive
Mar 13, 2025

On March 13, 2025, FitLife Brands announced its participation in the 37th Annual Roth Conference scheduled for March 17-18, 2025, and provided a financial and operational update. The company anticipates a significant increase in its financial performance for the full year 2024, with net revenue expected to rise by 21-23%, adjusted EBITDA by 38-40%, and net income by 68-72% compared to 2023. As of December 31, 2024, FitLife had $13.1 million outstanding on its term loan and $4.5 million in cash, with no balance on its revolver.

Stock Split
FitLife Brands Announces 2-for-1 Stock Split
Positive
Feb 5, 2025

On February 5, 2025, FitLife Brands announced a 2-for-1 forward stock split of its common stock, which will take effect on February 6, 2025, with trading on a split-adjusted basis starting February 7, 2025, on the Nasdaq Capital Market. This move, approved by the Board of Directors without requiring stockholder approval, aims to increase the stock’s daily trading volumes and make it more accessible to a broader range of investors. The forward split doubles the number of outstanding shares from 4.6 million to 9.2 million but does not alter stockholders’ percentage ownership or voting power.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.